Events2nd Canadian Peptide and Protein Community Virtual Meeting
Published
This submission belongs to the session Posters. Poster Session of the event 2nd Canadian Peptide and Protein Community Virtual Meeting
Published date
09 Nov, 2024
Academic Editor
author-avatarWilliam D. Lubell
Citation
Maryam Ali, Jumi Shin, Afnan Khan, Directed Evolution using a Deaminase Mutator in T7 Bacterial Systems, in Proceedings of 2nd Canadian Peptide and Protein Community Virtual Meeting, 16 December 2024, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Directed Evolution using a Deaminase Mutator in T7 Bacterial Systems

Afnan Khan 1
1. University of Toronto, Canada
Abstract

Protein engineering is an important tool for modifying biomolecules and can be classified into two categories: rational design and directed evolution. Combined with rational design, we use Phage Assisted Non-Continuous Evolution (PANCE), in which the protein of interest (POI) is subjected to cycles of mutagenesis and selection to improve its structure and function. Due to lack of specificity and low mutation rates observed with other mutagenesis plasmids, we shifted to the eMutaT7 mutagenesis plasmid in our viral PANCE system to mutate genes. Since the cytidine deaminase in eMutaT7 is fused to T7 RNA Polymerase, the addition of the T7 promoter and terminator encourages accumulation of mutations in the POI only. We will present the application of our viral eMutaT7 Phage Assisted Evolution (eMPAE) system to evolve proteins that bind specifically to large DNA target ligands. In this way, we are optimizing our system for phage-assisted evolution toward evolving DNA-binding proteins by circumventing the limitations of other bacterial mutagenesis plasmids.

Keywords
phage assisted evolution
directed evolution
cytidine deaminase
T7 bacterial systems
mutagenesis
eMutaT7
Poster
CPPC 2024 Poster.pdf
Peptide nanocarriers incorporated with adaptogens
Advances in drug discovery on the biofunctionalities of bioactive peptides: The role that molecular docking plays in targeted therapy development